CPI-893

N/A

Report date: 2022/07/13 15:24:30
NME

Base Information

Drug NameCPI-893
Drug Alias NameCPI-893
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase ITK/TSK inhibitors
TargetsTyrosine-protein kinase ITK/TSK
Therapy Area/IndicationsLymphoma, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCorvus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCorvus Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, T-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A